Cargando…
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
Multiple sclerosis (MS) has traditionally been considered an autoimmune inflammatory disorder leading to demyelination and clinical debilitation as evidenced by our current standard anti-inflammatory and immunosuppressive treatment regimens. While these approaches do control the frequency of clinica...
Autores principales: | Su, Kimmy, Bourdette, Dennis, Forte, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722885/ https://www.ncbi.nlm.nih.gov/pubmed/23898299 http://dx.doi.org/10.3389/fphys.2013.00169 |
Ejemplares similares
-
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges
por: Su, Kimmy, et al.
Publicado: (2012) -
Commentary: The m-AAA Protease Associated with Neurodegeneration Limits MCU Activity in Mitochondria
por: Bernardi, Paolo, et al.
Publicado: (2016) -
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
por: Campbell, Graham R, et al.
Publicado: (2011) -
New oral disease-modifying therapies for multiple sclerosis
por: Bagert, Bridget A, et al.
Publicado: (2009) -
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
por: Correale, Jorge, et al.
Publicado: (2019)